AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 282: E977-E981, 2002; doi:10.1152/ajpendo.00561.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hribal, M. L.
Right arrow Articles by Accili, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hribal, M. L.
Right arrow Articles by Accili, D.
Vol. 282, Issue 5, E977-E981, May 2002

INVITED REVIEW
Mouse models of insulin resistance

Marta Letizia Hribal, Francesco Oriente, and Domenico Accili

Naomi Berrie Diabetes Center, Department of Medicine, College of Physicians & Surgeons of Columbia University, New York, New York 10032

The hallmarks of type 2 diabetes are impaired insulin action in peripheral tissues and decreased pancreatic beta -cell function. Classically, the two defects have been viewed as separate entities, with insulin resistance arising primarily from impaired insulin-dependent glucose uptake in skeletal muscle, and beta -cell dysfunction arising from impaired coupling of glucose sensing to insulin secretion. Targeted mutagenesis and transgenesis involving components of the insulin action pathway have changed our understanding of these phenomena. It appears that the role of insulin signaling in the pathogenesis of type 2 diabetes has been overestimated in classic insulin target tissues, such as skeletal muscle, whereas it has been overlooked in liver, pancreatic beta -cells, and brain, which had been thought not to be primary insulin targets. We review recent progress and try to reconcile areas of apparent controversy surrounding insulin signaling in skeletal muscle and pancreatic beta -cells.

knockout mice; genetics; beta -cells; hormone receptors


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. L. Jetton, B. Everill, J. Lausier, V. Roskens, A. Habibovic, K. LaRock, A. Gokin, M. Peshavaria, and J. L. Leahy
Enhanced {beta}-cell mass without increased proliferation following chronic mild glucose infusion
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E679 - E687.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Lee, R. Muniyappa, X. Yan, H. Chen, L. Q. Yue, E.-G. Hong, J. K. Kim, and M. J. Quon
Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E261 - E270.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Okada, C. W. Liew, J. Hu, C. Hinault, M. D. Michael, J. Krtzfeldt, C. Yin, M. Holzenberger, M. Stoffel, and R. N. Kulkarni
From the Cover: Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance
PNAS, May 22, 2007; 104(21): 8977 - 8982.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. J. Horvath, H. Vittal, and T. Ordog
Reduced Insulin and IGF-I Signaling, not Hyperglycemia, Underlies the Diabetes-Associated Depletion of Interstitial Cells of Cajal in the Murine Stomach
Diabetes, May 1, 2005; 54(5): 1528 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Dong, B. A. Maddux, J. Altomonte, M. Meseck, D. Accili, R. Terkeltaub, K. Johnson, J. F. Youngren, and I. D. Goldfine
Increased Hepatic Levels of the Insulin Receptor Inhibitor, PC-1/NPP1, Induce Insulin Resistance and Glucose Intolerance
Diabetes, February 1, 2005; 54(2): 367 - 372.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Lang and R. A. Frost
Differential effect of sepsis on ability of leucine and IGF-I to stimulate muscle translation initiation
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E721 - E730.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
J. Kaput, K. G. Klein, E. J. Reyes, W. A. Kibbe, C. A. Cooney, B. Jovanovic, W. J. Visek, and G. L. Wolff
Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions
Physiol Genomics, August 11, 2004; 18(3): 316 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. NANDI, Y. KITAMURA, C. R. KAHN, and D. ACCILI
Mouse Models of Insulin Resistance
Physiol Rev, April 1, 2004; 84(2): 623 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. W. Cohen, T. P. Combs, P. E. Scherer, and M. P. Lisanti
Role of caveolin and caveolae in insulin signaling and diabetes
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1151 - E1160.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online